A new step toward non-genotoxic conditioning prior to hematopoietic stem cell transplantation

被引:0
|
作者
Cavazzana, Marina [1 ,2 ,3 ,4 ]
Calvo, Charlotte [1 ,5 ,6 ]
机构
[1] Univ Paris Cite, Paris, France
[2] Hop Necker Enfants Malad, AP HP, Dept Biotherapie, Paris, France
[3] Ctr Invest Clin Biotherapie, INSERM UMR1163, Paris, France
[4] Imagine Inst, Paris, France
[5] Robert Debre Hosp, AP HP, Dept Paediat Immunol & Haematol, Paris, France
[6] Inst Rech SaintLouis, INSERM U976, Paris, France
关键词
ANTIBODY-DRUG CONJUGATE;
D O I
10.1016/j.ymthe.2024.05.025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1604 / 1605
页数:2
相关论文
共 50 条
  • [11] Non-Genotoxic Restoration of the Hematolymphoid System in Fanconi Anemia Mice through Antibody-Mediated Hematopoietic Stem Cell Transplantation
    Chan, Yan Yi
    Ho, Pui Yan
    Swartzrock, Leah
    Rayburn, Maire
    Nofal, Rofida
    Thongthip, Supawat
    Weinberg, Kenneth I.
    Czechowicz, Agnieszka
    BLOOD, 2022, 140 : 7342 - 7344
  • [12] High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation
    Glowka, Franciszek K.
    Romanski, Michal
    Wachowiak, Jacek
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (10) : 1275 - 1295
  • [13] The Gonadotoxic Effects of Conditioning Chemotherapy Regimens Prior to Hematopoietic Stem Cell Transplantation
    Jiang, Heng
    Dong, Rosemary
    Kim, So-Youn
    Luan, Yi
    Thonen, Macy
    Wadhwa, Aman
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 22S - 22S
  • [14] Hematopoietic stem cell transplantation using non-genotoxic anti-CD117 immunotoxin conditioning corrects immune deficiencies and restores immune function in ataxia telangiectasia mice
    Russell, Athena
    Prince, Chengyu
    Kumar, Deepak
    Knight, Kristopher
    Rayaprolu, Sruti
    Xiao, Hailian
    Rangaraju, Srikant
    Spencer, H. Trent
    Doering, Christopher
    Chandrakasan, Shanmuganathan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S134 - S134
  • [15] NEW NON-GENOTOXIC CONDITIONING REGIMES FOR TRANSPLANTATION OF HAEMATOPOIETIC PROGENITORS IN PRIMARY IMMUNODEFICIENCIES: TA AS PROOF OF CONCEPT
    Ana Cristina, Vinado
    Isabel, Calvo
    Itziar, Cenzano
    Jose J, Rifon
    Felipe, Prosper
    Borja, Saez
    HAEMATOLOGICA, 2021, 106 (10) : 42 - 43
  • [16] Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency
    Agarwal, Rajni
    Dvorak, Christopher C.
    Kwon, Hye-Sook
    Long-Boyle, Janel R.
    Prohaska, Susan S.
    Brown, Janice W.
    Le, Anne
    Guttman-Klein, Alyssa
    Weissman, Irving L.
    Cowan, Morton J.
    Logan, Aaron C.
    Weinberg, Kenneth I.
    Parkman, Robertson
    Roncarolo, Maria-Grazia
    Shizuru, Judith A.
    BLOOD, 2019, 134
  • [17] Intravenous busulfan: In the conditioning treatment of pediatric patients prior to hematopoietic stem cell transplantation
    Hoy S.M.
    Lyseng-Williamson K.A.
    Pediatric Drugs, 2007, 9 (4) : 271 - 278
  • [18] Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation
    Hassan, Moustapha
    Andersson, Borje S.
    PHARMACOGENOMICS, 2013, 14 (01) : 75 - 87
  • [19] Improving conditioning regimen prior to allogeneic hematopoietic stem cell transplantation in acute leukaemia
    Greco, Raffaella
    Morelli, Mara
    Giglio, Fabio
    Stanghellini, Maria Teresa Lupo
    Assanelli, Andrea
    Ciceri, Fabio
    Peccatori, Jacopo
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 5 - 13
  • [20] Non-Genotoxic Conditioning Approach for Autologous Hematopoietic Stem Cell Therapies through Transient mRNA Engineering Using Vector-Free Microfluidic Cell Squeeze® Technology
    Silva, Murillo
    Bartlett, Cara
    Hanson, Jacquelyn
    Gilbert, Jonathan
    Bridgen, Devin
    BLOOD, 2022, 140 : 4495 - 4495